The Future of the Generics Industry: Opportunities, Threats and Key Trends Now Available at ReportsandReports

Driven by rising demand, patent expiries and pharmaceutical cost-containment policies, generic sales have risen consistently at rates in excess of the pharmaceutical industry average over the past decade. Coupled with changes in the geographic and therapeutic make-up of the sector, this has triggered a period of rapid restructuring within the generics industry

Dallas, TX, October 25, 2010 --(PR.com)-- ReportsandReports announce The Future of the Generics Industry: Opportunities, threats and key trends Market Research Report in its Store.

Browse complete Report at: The Future of the Generics Industry: Opportunities, threats and key trends http://www.reportsandreports.com/reports/33136-the-future-of-the-generics-industry-opportunities-threats-and-k.html.

Report Summary
Driven by rising demand, patent expiries and pharmaceutical cost-containment policies, generic sales have risen consistently at rates in excess of the pharmaceutical industry average over the past decade. Coupled with changes in the geographic and therapeutic make-up of the sector, this has triggered a period of rapid restructuring within the generics industry. Teva and Sandoz have consolidated their positions at the head of the generic company sales rankings; national and regional businesses have emerged as major forces in emerging generic markets; while new players – including multinationals – have begun to pursue footholds in the generics sector.

Demand for generics will continue to increase rapidly during the next five years. Major patent expiries will present generic manufacturers with substantial new targets – including the world’s best-selling pharmaceutical brand, Lipitor. Sales of branded copies will rise at double-digit rates in many developing countries, while unbranded, bioequivalent follow-on products will be prescribed, dispensed and consumed more widely in some of the world’s biggest markets. Governments and third-party payers will adopt more robust pro-generic policies in a bid to limit pharmaceutical spending. These will include measures designed to encourage the use of biosimilars, which will help to rein in costs associated with the reimbursement of expensive biotech drugs.

While demand for generics will remain strong, pressure on prices in the sector will intensify as competition heats up, and as payers step up their efforts to limit reimbursement spending. Generic manufacturers will also have to overcome barriers to market entry posed by intellectual property laws, regulatory frameworks and defensive strategies employed by originator companies. Levels of brand affinity that persist among physicians, pharmacists and patients will also act as a constraint on rates at which generics are prescribed, dispensed and consumed.

Key Features of this report
Analysis of the size, structure and recent growth of the global generics market, and of the industry it supports.
Case studies focusing on individual generic businesses and key generic markets.
Identification and detailed discussion of key generic industry drivers and constraints.
Appraisal of the impact individual drivers and constraints will have on the market to 2015.
Forecasts outlining the anticipated size and structure of the generics market in 2015, assessing future prospects for individual generic businesses and identifying potential major new entrants in the sector.

Key Benefits of this report
Quantify the size and structure of current opportunities in the generics market and the positions held by key players in the sector.
Identify the main factors acting as drivers and constraints on generic market growth, and gauge their likely impact on the structure of the industry.
Assess the timing and extent of new opportunities that patent expiries will present for generic manufacturers during the next five years.
Track the development of pro-generic healthcare policies implemented in key markets, and their likely impact on the industry.

Key questions answered by this report
Why has the generics market enjoyed such strong growth in recent years, and what are the main factors that will determine its development through the next five years and beyond?
What makes markets like Japan and Brazil such attractive targets for generic manufacturers, and why have foreign players struggled to make an impact in these countries?

Browse all Healthcare Market Research Reports
http://www.reportsandreports.com/cat/healthcare-market-research.html

Browse all Business Insights Market Research Reports
http://www.reportsandreports.com/Publisher/business-insights-market-research.html-market-research.html

Browse all Newly Published Market Research Reports http://www.reportsandreports.com/LatestReport.aspx

Original Source: Generics Industry
Buy Now: Research

Related Reports:
The Specialty Pharmaceutical Market Outlook: Key players, opportunities and future trends
http://www.reportsandreports.com/reports/16256-the-specialty-pharmaceutical-market-outlook-key-players-opportu.html

Generics Series: Generics Trends in the Seven Major Markets and Beyond
http://www.reportsandreports.com/reports/9348-generics-series-generics-trends-in-the-seven-major-markets-and-b.html

Trends in Generics Industry Ownership: Evaluating changing industry paradigms and emerging players
http://www.reportsandreports.com/reports/32529-trends-in-generics-industry-ownership-evaluating-changing-indust.html

Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
http://www.reportsandreports.com/reports/8603-future-pharmaceutical-industry-trends-long-term-opportunities-te.html

Generics Growth Strategies: Cost containment and M&A shape the global generics industry
http://www.reportsandreports.com/reports/7362-generics-growth-strategies-cost-containment-and-ma-shape-the-gl.html

About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/

###
Contact
MarketsandMarkets
Sunita Christ
+1-888-989-8004
http://www.marketsandmarkets.com/Market-Reports/silicon-photonics-116.html
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
ContactContact
Categories